Health ❯ Research ❯ Clinical Trials
Flavan-3-ols Effects DECAF Trial Atrial Fibrillation Studies
The AHA-presented, JAMA-published study supports allowing habitual coffee drinkers to continue moderate intake after cardioversion.
